Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recent studies have shown that C natriuretic peptide (CNP) is produced from granulosa cells, increasing cumulative guanosine monophosphate (cGMP) production by affecting cumulus cells through natriuretic peptide receptors.It has been suggested that the transport of cGMP to oocyte via gap junctions causes a continuous increase in cyclic adenosine monophosphate (cAMP) levels within the oocyte. An important role of increased cAMP levels in oocyte is shown to suppress meiotic progression. Deoxyribonucleic acid (DNA) studies in animals have shown that expression of the natriuretic peptide precursor increases during the periovulatory period and shows that this increase decreases rapidly after Luteinizing hormone(LH) / human chorionic(hCG) stimulation. Human studies have shown that after ovulation induction, the CNP level in follicular fluid decreases following ovulatory dose of hCG (9).
In this prospective study, 60 patients are planned to recruite. Group 1 consists of 20 healthy reproductive aged women between 18-40 years old, with regular menstruation. Group 2 will include 20 patients in perimenopausal time period between 40-49 ages and in group 3 there will be20 postmenopausal women.
Age, gravida, parity and body mass index (BMI) data of all patients will be recorded. BMI is calculated by dividing the body weight in kilograms by the square of the height in meters. All patients will go under ultrasound examination by the same clinician (ACO). The number of antral follicles in group 1 and group 2 will be recorded. In addition, on the 2nd or 3rd day of menstruation, serum FSH, LH and E2 data of the patients in group 1 and 2 will be recorded.
For the last 6 months, patients with drug use that may affect menstruation like oral contraceptives, patients with cardiac or renal disease and therefore drug use, causes of infertility other than unexplained infertility, history of ovarian surgery, presence of polycystic ovary syndrome, and patients with irregular menstruation will be excluded for the study. In addition, patients with renal, cardiac, central nervous system and endocrine diseases will be excluded.
Morning fasting venous blood samples will be taken from the patients on the 2nd or 3rd day of the menstruation for group 1 and 2. All blood samples will be centrifuged on the day of collection and separated serum samples and will be kept at -80 degrees until the day of CNP test. Serum CNP levels of the patients will be analyzed by an enzyme-linked immunosorbent (ELISA) assay for human CNP in accordance with the manufacturer's instructions (SEA721Hu, ELISA Kit for Human CNP, Wuhan USCN Business Co., Ltd., Cloud-Clone Corp., CCC, USA).
Data will be analyzed using Statistical Package for Social Sciences software (SPSS v15, SPSS Inc, Chicago, IL, USA). The variables will be investigated using visual and analytical methods (histograms, homogeneity of variances test, Kolmogorov-Simirnov/Shapiro-Wilk's test) to determine whether or not they are normally distributed. Patient demographics and CNP values will be presented as median ± interquartile range. Gravida and parity will be demonstrated by frequency distribution. The correlation coefficients and their significance will be calculated using the Spearman test. P-values less than 0.05 will be regarded as statistically significant.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Reproductive age women | Active Comparator | The healthy women between 18-40 years old. |
|
| Perimenopausal women | Active Comparator | The healthy women between 40-49 years old. |
|
| Postmenopausal women | Active Comparator | The healthy women that has been in to menopause more than a year |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| C Type Natriüretic Peptide | Diagnostic Test | C Type Natriuretic Peptide will be measured with elisa method |
|
| Measure | Description | Time Frame |
|---|---|---|
| Serum C Type Natriuretic Peptide Levels | The comparison of serum levels of C type natriuretic peptide among different age groups | Second or Third Day of Menstruation |
| Measure | Description | Time Frame |
|---|---|---|
| Correlation Between Serum CNP and Follicle Stimulating Hormone and Luteinizing Hormone Levels in Groups 1 and 2 | Correlations between serum CNP vs Follicle Stimulating Hormone(FSH), CNP vs Luteinizing Hormone(LH) levels in groups 1 and 2 | Second or Third Day of Menstruation |
| Correlation Between Serum CNP and Antral Follicle Count (AFC) in Groups 1 and 2 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Female participants will be included
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Özay | Near East University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Near East University Faculty of Medicine | Nicosia | 99138 | Cyprus |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 20947764 | Background | Zhang M, Su YQ, Sugiura K, Xia G, Eppig JJ. Granulosa cell ligand NPPC and its receptor NPR2 maintain meiotic arrest in mouse oocytes. Science. 2010 Oct 15;330(6002):366-9. doi: 10.1126/science.1193573. | |
| 19429786 | Background | Norris RP, Ratzan WJ, Freudzon M, Mehlmann LM, Krall J, Movsesian MA, Wang H, Ke H, Nikolaev VO, Jaffe LA. Cyclic GMP from the surrounding somatic cells regulates cyclic AMP and meiosis in the mouse oocyte. Development. 2009 Jun;136(11):1869-78. doi: 10.1242/dev.035238. |
Not provided
Not provided
Only the name of study
Not provided
Not provided
Not provided
Not provided
For the last 6 months, patients with drug use that may affect menstruation like oral contraceptives, patients with cardiac or renal disease and therefore drug use, causes of infertility other than unexplained infertility, history of ovarian surgery, presence of polycystic ovary syndrome, and patients with irregular menstruation.
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Reproductive Age Women | The healthy women between 18-40 years old. C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method |
| FG001 | Perimenopausal Women | The healthy women between 40-49 years old. C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method |
| FG002 | Postmenopausal Women | The healthy women that has been in to menopause more than a year C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Reproductive Age Women | The healthy women between 18-40 years old. C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method |
| BG001 | Perimenopausal Women |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Serum C Type Natriuretic Peptide Levels | The comparison of serum levels of C type natriuretic peptide among different age groups | Posted | Median | Inter-Quartile Range | pg/ml | Second or Third Day of Menstruation |
|
Adverse events were not assessed.
Adverse events were not assessed.
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Reproductive Age Women | The healthy women between 18-40 years old. C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method |
Not provided
Not provided
The most prominent limitation of our study was the relatively small number of participants. This avoided us from using more powerful parametric tests for statistical analysis.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr.Ali Cenk Ozay | Dr.Ali Cenk Ozay | 00905428583248 | dr.alicenk@hotmail.com |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jan 21, 2020 | Jan 24, 2020 | Prot_SAP_000.pdf |
Not provided
In this study, there are three groups. Group 1:Women between 18-40 age, Group 2:Perimenopausal women (40-49 years), Group 3: Postmenopausal women.
Not provided
Not provided
Not provided
Correlation between serum CNP and antral follicle count (AFC) in groups 1 and 2 using Spearman test |
| Second or Third Day of Menstruation |
| Correlation Between Serum CNP and Estradiol Levels in Groups 1 and 2 | Correlation of CNP vs. Estradiol levels in reproductive age and perimenopausal women | Second or Third Day of Menstruation |
| 19474061 | Background | Vaccari S, Weeks JL 2nd, Hsieh M, Menniti FS, Conti M. Cyclic GMP signaling is involved in the luteinizing hormone-dependent meiotic maturation of mouse oocytes. Biol Reprod. 2009 Sep;81(3):595-604. doi: 10.1095/biolreprod.109.077768. Epub 2009 May 27. |
| 8812137 | Background | Tsafriri A, Chun SY, Zhang R, Hsueh AJ, Conti M. Oocyte maturation involves compartmentalization and opposing changes of cAMP levels in follicular somatic and germ cells: studies using selective phosphodiesterase inhibitors. Dev Biol. 1996 Sep 15;178(2):393-402. doi: 10.1006/dbio.1996.0226. |
| 11944932 | Background | Thomas RE, Armstrong DT, Gilchrist RB. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation. Dev Biol. 2002 Apr 15;244(2):215-25. doi: 10.1006/dbio.2002.0609. |
| 12773402 | Background | Nogueira D, Albano C, Adriaenssens T, Cortvrindt R, Bourgain C, Devroey P, Smitz J. Human oocytes reversibly arrested in prophase I by phosphodiesterase type 3 inhibitor in vitro. Biol Reprod. 2003 Sep;69(3):1042-52. doi: 10.1095/biolreprod.103.015982. Epub 2003 May 28. |
| 23255339 | Background | Lee KB, Zhang M, Sugiura K, Wigglesworth K, Uliasz T, Jaffe LA, Eppig JJ. Hormonal coordination of natriuretic peptide type C and natriuretic peptide receptor 3 expression in mouse granulosa cells. Biol Reprod. 2013 Feb 21;88(2):42. doi: 10.1095/biolreprod.112.104810. Print 2013 Feb. |
| 23331536 | Background | Hiradate Y, Hoshino Y, Tanemura K, Sato E. C-type natriuretic peptide inhibits porcine oocyte meiotic resumption. Zygote. 2014 Aug;22(3):372-7. doi: 10.1017/S0967199412000615. Epub 2013 Jan 18. |
| 21865234 | Background | Kawamura K, Cheng Y, Kawamura N, Takae S, Okada A, Kawagoe Y, Mulders S, Terada Y, Hsueh AJ. Pre-ovulatory LH/hCG surge decreases C-type natriuretic peptide secretion by ovarian granulosa cells to promote meiotic resumption of pre-ovulatory oocytes. Hum Reprod. 2011 Nov;26(11):3094-101. doi: 10.1093/humrep/der282. Epub 2011 Aug 23. |
| Right ovarian cyst occured |
|
| Hypertension occured on follow up |
|
The healthy women between 40-49 years old.
C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method
| BG002 | Postmenopausal Women | The healthy women that has been in to menopause more than a year C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method |
| BG003 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race and Ethnicity Not Collected | Race and Ethnicity were not collected from any participant. | Count of Participants | Participants |
|
| Region of Enrollment | Count of Participants | Participants |
|
| BMI | Mean | Standard Deviation | kg/m^2 |
|
| Postmenopausal Women |
The healthy women that has been in to menopause more than a year C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method |
|
|
|
| Secondary | Correlation Between Serum CNP and Follicle Stimulating Hormone and Luteinizing Hormone Levels in Groups 1 and 2 | Correlations between serum CNP vs Follicle Stimulating Hormone(FSH), CNP vs Luteinizing Hormone(LH) levels in groups 1 and 2 | FSH and LH should be evaluated during menstruation time period ( day 3). In postmenopausal women there is no spesific date to evaluate these hormones since they do not have menstruation. Therefore in postmenopausal arm group these hormones (FSH and LH) are not studied. | Posted | Median | Inter-Quartile Range | mIU/mL | Second or Third Day of Menstruation |
|
|
|
|
| Secondary | Correlation Between Serum CNP and Antral Follicle Count (AFC) in Groups 1 and 2 | Correlation between serum CNP and antral follicle count (AFC) in groups 1 and 2 using Spearman test | AFC should be evaluated during menstruation time period ( day 3). In postmenopausal women there is no spesific date to evaluate AFC value since they do not have menstruation. Therefore in postmenopausal arm group AFC value is not studied. | Posted | Mean | Standard Deviation | follicles | Second or Third Day of Menstruation |
|
|
|
|
| Secondary | Correlation Between Serum CNP and Estradiol Levels in Groups 1 and 2 | Correlation of CNP vs. Estradiol levels in reproductive age and perimenopausal women | Estradiol should be evaluated during menstruation time period ( day 3). In postmenopausal women there is no spesific date to evaluate this hormone since they do not have menstruation. Therefore in postmenopausal arm group this hormone is not studied. | Posted | Median | Inter-Quartile Range | pg/mL | Second or Third Day of Menstruation |
|
|
|
|
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| EG001 | Perimenopausal Women | The healthy women between 40-49 years old. C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method | 0 | 0 | 0 | 0 | 0 | 0 |
| EG002 | Postmenopausal Women | The healthy women that has been in to menopause more than a year C Type Natriüretic Peptide: C Type Natriuretic Peptide will be measured with elisa method | 0 | 0 | 0 | 0 | 0 | 0 |
Not provided
Not provided
| Male |
|